Please provide your email address to receive an email when new articles are posted on . KOLOA, Hawaii — Local steroid therapy can be beneficial for less severe uveitis, short-term uveitis and uveitic ...

The MarketWatch News Department was not involved in the creation of this content. Vyome's offering is a first-of-its-kind in a broader $20B potential addressable ocular inflammation market VT-1908 ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

An estimated five to ten percent of blindness worldwide is caused by the rare inflammatory eye disease uveitis. Posterior uveitis in particular is often associated with severe disease progression and ...

SEATTLE — Uveitis expert Nisha Acharya, MD, shared three clinical pearls on the condition at the American Society of Retina Specialists (ASRS) 2023 Annual Meeting. "Chronic or recurrent uveitis ...

Syphilitic uveitis cases requiring hospitalization increased from 2010 to 2019 in the U.S., amid a national shortage of the standard-of-care injectable penicillin G, according to a retrospective cross ...

WENZHOU, China, Jan. 6, 2026 /PRNewswire/ -- Recently, VivaVision Biotech (VivaVision), a late clinical-stage, privately-held biotech company focused on developing innovative ophthalmic drugs, ...

Early-onset, chronic nonanterior uveitis in children increases the risk of ocular complications, with 44.3% experiencing issues like cataracts and macular edema. Persistent chronic uveitis is a ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. A 29-year-old woman was referred to Tufts Medical Center ...

Vyome Presents Strong Data Showing Topical VT-1908 is an Effective Treatment for Uveitis, Opening Up a $3B Addressable Market Opportunity Vyome’s offering is a first-of-its-kind in a broader $20B ...